Article
Alternative splicing in prostate cancer progression and therapeutic resistance
24 Apr 2024
Abstract excerpt
Prostate cancer (CaP) remains the second leading cause of cancer deaths in western men. CaP mortality results from diverse molecular mechanisms that mediate resistance to the standard of care treatments for metastatic disease. Recently, alternative splicing has been recognized as a hallmark of CaP aggressiveness. Alternative splicing events cause treatment resistance and aggressive CaP behavior and are...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
